We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$159M
AUM Growth
-$1.35M
Cap. Flow
-$550K
Cap. Flow %
-0.35%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
YMAB
Y-mAbs Therapeutics
YMAB
+$550K

Sector Composition

Rank Sector Weight
1 Healthcare 85.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$25.6B
$107M 67.12%
2,680,644
– –
GDX icon
2
VanEck Gold Miners ETF
GDX
$27.6B
$23.7M 14.86%
738,500
– –
CRBU icon
3
Caribou Biosciences
CRBU
$164M
$10.2M 6.39%
674,196
– –
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.43B
$8.85M 5.56%
602,272
– –
ILMN icon
5
Illumina
ILMN
$29.1B
$6.54M 4.11%
17,677
– –
YMAB
6
DELISTED
Y-mAbs Therapeutics
YMAB
$3.1M 1.95%
191,176
-25,740
-12% -$550K

Similar funds

BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Memorial Sloan Kettering Cancer Center's Q4 2021 Portfolio in Review

As of Q4 2021, Memorial Sloan Kettering Cancer Center held 6 positions worth $159M, down 0.84% from $160M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. Memorial Sloan Kettering Cancer Center opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 86% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's biggest Q4 2021 reduction was Y-mAbs Therapeutics, cutting an estimated $550K.
  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $159M portfolio in Q4 2021.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 0 in Q4 2021.
  • Memorial Sloan Kettering Cancer Center's portfolio value fell 0.84% quarter-over-quarter to $159M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q4 2021, filed 14 Feb 2022.